SAN DIEGO – Dec. 12, 2016 – Millennium Health, a leading health solutions company, announced today the availability of a new definitive urine drug test for detecting the opioid medication levorphanol using LC-MS/MS technology. The addition is in response to requests from clinicians who prescribe levorphanol and want to include urine drug monitoring as part of a comprehensive treatment plan.Read More
SAN DIEGO – Nov. 17, 2016 – Millennium Health, a leading health solutions company, and Brightpoint Health, a nonprofit medical and mental health care provider, announced the publication of a new study that suggests medically necessary medication monitoring definitive drug testing using Liquid Chromatography with Tandem Mass Spectrometry (LC-MS/MS), can help clinicians enhance treatment outcomes in Substance Use Disorders (SUDs). The study was published in the “Journal of Addiction Medicine.”Read More
Leading F500 Directors and Governance Experts to be recognized in NYC on Nov. 30
PLANO, TX – August 2, 2016 – Millennium Health Chairman of the Board and Chief Executive Officer Ron Rittenmeyer has been named to The National Association of Corporate Directors’ (NACD) 2016 Directorship 100 list, a distinguished honor that annually recognizes the most influential leaders in the boardroom and corporate governance community.
Seasoned executives provide decades of health care experience
SAN DIEGO – Aug. 1, 2016 – Millennium Health, a leading health solutions company, today announced the appointment of Joan B. Stafslien and Jeffrey D. Goldberg to its Board of Directors. Stafslien and Goldberg join current members Eugene I. Davis, Stephen Gray, and Chairman of the Board and Chief Executive Officer Ron Rittenmeyer.Read More
Arnst brings more than 25 years of legal, compliance, human resources, risk management and administration experience.
SAN DIEGO – July 25, 2016 – Millennium Health, a leading health solutions company, today announced the appointment of Thomas W. Arnst as Chief Administrative Officer. In this newly created position, Arnst will head the legal and human resources functions and report directly to Chairman of the Board and Chief Executive Officer Ronald A. Rittenmeyer.Read More
Gene testing is showing promise as a tool to get the right medication at the right dose to each workers' compensation patient.
Pharmacogenetic testing (PGT) has the potential to help clinicians improve outcomes for injured workers and reduce costs for payers. While research showing the clinical value of PGT continues to grow rapidly, evidence of the return on investment in the workers’ comp space is just beginning to emerge. Practitioners can benefit from the technology without falling victim to the hype of some proponents by becoming better educated about PGT and those providing it.Read More
San Diego – June 13, 2016 – Millennium Health, a leading health solutions company, today announced the appointment of Michael Keane as chief financial officer. Keane will report directly to Chairman of the Board and CEO Ronald A. Rittenmeyer.Read More
Variability in medication response among patients is a well-known challenge for health care providers. Millennium pharmacogenetic testing (PGT) helps providers optimize the use of medications by delivering timely, accurate, clinically actionable information to inform the right treatment decisions for each patient.Read More
Brian suffered from depression for 25 years and was prescribed many medications that were ineffective. Looking for new therapies to combat his illness, he found Dr. Edgar Castillo-Armas, a clinician who has gone beyond the trial and error approach. Read More
Customer Service
(RADAR® / MAPP® Hotline)
(866) 866-0605
clientservices@millenniumhealth.com
Monday–Friday 5:00AM-5:30PM PT
Patient Billing
(877) 451-7337
Monday-Friday 6:00AM-5:00PM PT
Corporate Headquarters
(877) 451-3534
